Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2026-04-06 @ 2:59 PM
Study NCT ID:
NCT03113812
Status:
COMPLETED
Last Update Posted:
2017-04-14
First Post:
2017-04-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients
Sponsor:
Araclon Biotech S.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2015-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-04
First Submit QC Date:
None
Study First Post Date:
2017-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-10
Last Update Post Date:
2017-04-14
Last Update Post Date Type:
ACTUAL